VKTX: Viking Therapeutics Inc. Stocks News on October 8, 2025

VKTX

Zacks

6 days ago

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

VKTX

Insider Monkey

8 days ago

BTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX) With a $125 PT

Why This Weight Loss Drug Company's Stock Surged Today

VKTX

Motley Fool

3 months ago

Why This Weight Loss Drug Company's Stock Surged Today

Viking commences Phase III clinical programme of VK2735 for obesity

VKTX

Clinical Trials Arena

3 months ago

Viking commences Phase III clinical programme of VK2735 for obesity

VKTX

Zacks

3 months ago

VKTX Initiates Phase 3 Study on Obesity Candidate VK2735

VKTX

Motley Fool

3 months ago

3 Growth Stocks I'm Loading Up On

Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity

VKTX

Investor's Business Daily

3 months ago

Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity

VKTX

MT Newswires

3 months ago

Viking Therapeutics Begins Phase 3 Trial of Dual Agonist VK2735 in Obesity

VKTX

PR Newswire

3 months ago

Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

VKTX

Motley Fool

4 months ago

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

VKTX

Zacks

4 months ago

Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should Know

Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.

VKTX

Motley Fool

4 months ago

Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.

VKTX

Zacks

4 months ago

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks?

VKTX

Motley Fool

4 months ago

Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks?

VKTX

Insider Monkey

4 months ago

Viking Therapeutics (VKTX) Rises on Expected Developments

VKTX

Zacks

4 months ago

Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note

VKTX

Simply Wall St.

4 months ago

We're Hopeful That Viking Therapeutics (NASDAQ:VKTX) Will Use Its Cash Wisely

VKTX

Insider Monkey

4 months ago

Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)?

1 Stock Down 34% This Year to Buy and Hold

VKTX

Motley Fool

4 months ago

1 Stock Down 34% This Year to Buy and Hold

VKTX

Zacks

4 months ago

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know

Could Viking Therapeutics Become the Next Eli Lilly?

VKTX

Motley Fool

4 months ago

Could Viking Therapeutics Become the Next Eli Lilly?

VKTX

Motley Fool

4 months ago

3 Best Growth Stocks to Buy in June

VKTX

Zacks

4 months ago

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?

Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?

VKTX

Zacks

4 months ago

Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?

Better Weight Loss Stock: Amgen or Viking Therapeutics?

VKTX

Motley Fool

5 months ago

Better Weight Loss Stock: Amgen or Viking Therapeutics?

Why Viking Therapeutics Stock Bumped 3% Higher Today

VKTX

Motley Fool

5 months ago

Why Viking Therapeutics Stock Bumped 3% Higher Today

Novo Nordisk Sheds 3% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price

VKTX

Investor's Business Daily

5 months ago

Novo Nordisk Sheds 3% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years

VKTX

Motley Fool

5 months ago

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years

VKTX

Motley Fool

5 months ago

3 Monster Stocks in the Making

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April

VKTX

Motley Fool

5 months ago

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April

Why Viking Therapeutics Stock Was Victorious This Week

VKTX

Motley Fool

5 months ago

Why Viking Therapeutics Stock Was Victorious This Week

VKTX

Simply Wall St.

5 months ago

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

VKTX

Motley Fool

5 months ago

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

VKTX

Motley Fool

5 months ago

Is Novo Nordisk Stock a Buy?

Where Will Viking Therapeutics Be in 3 Years?

VKTX

Motley Fool

5 months ago

Where Will Viking Therapeutics Be in 3 Years?

1 Beaten-Down Stock to Buy and Hold for 10 Years

VKTX

Motley Fool

5 months ago

1 Beaten-Down Stock to Buy and Hold for 10 Years

Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

VKTX

Motley Fool

5 months ago

Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain

VKTX

Motley Fool

5 months ago

Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain

Why Viking Therapeutics Stock Popped Again Today

VKTX

Motley Fool

5 months ago

Why Viking Therapeutics Stock Popped Again Today

VKTX

MT Newswires

5 months ago

Cantor Fitzgerald Initiates Viking Therapeutics at Overweight With $104 Price Target

Why Viking Therapeutics Stock Popped Today

VKTX

Motley Fool

5 months ago

Why Viking Therapeutics Stock Popped Today

VKTX

MT Newswires

5 months ago

Truist Securities Cuts Viking Therapeutics Price Target to $75 From $95, Maintains Buy Rating

VKTX

Simply Wall St.

5 months ago

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss for Q1 2025

VKTX

MT Newswires

5 months ago

B. Riley Adjusts Price Target on Viking Therapeutics to $85 From $96, Maintains Buy Rating

VKTX

Thomson Reuters StreetEvents

5 months ago

Q1 2025 Viking Therapeutics Inc Earnings Call

Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips

VKTX

Zacks

5 months ago

Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips

VKTX

GuruFocus.com

5 months ago

Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising ...

VKTX

Insider Monkey

5 months ago

Viking Therapeutics, Inc. (VKTX): Among Takeover Rumors Hedge Funds Are Buying

VKTX

MT Newswires

5 months ago

Viking Therapeutics Q1 Loss Widens; Shares Drop After Hours

VKTX

MT Newswires

6 months ago

Oppenheimer Cuts Price Target on Viking Therapeutics to $100 From $164, Keeps Outperform Rating

VKTX

Zacks

6 months ago

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study

VKTX

Zacks

6 months ago

LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study

Viking Therapeutics to Report Q1 Earnings: What's in the Cards?

VKTX

Zacks

6 months ago

Viking Therapeutics to Report Q1 Earnings: What's in the Cards?

VKTX

Simply Wall St.

6 months ago

Viking Therapeutics (NasdaqCM:VKTX) Completes Enrollment For Phase 2 Trial Of VK2735

H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data

VKTX

TipRanks

6 months ago

H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data

Eli Lilly jumps as results from weight-loss pill study rival competitor’s

VKTX

TipRanks

6 months ago

Eli Lilly jumps as results from weight-loss pill study rival competitor’s

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

VKTX

TipRanks

6 months ago

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

VKTX

Zacks

6 months ago

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill

VKTX

Investor's Business Daily

6 months ago

Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

VKTX

Motley Fool

6 months ago

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

2 Stocks Down by 25% or More This Year to Buy and Hold

VKTX

Motley Fool

6 months ago

2 Stocks Down by 25% or More This Year to Buy and Hold

Eli Lilly Rockets 12% After Solidifying Its Lead For A Weight-Loss Pill

VKTX

Investor's Business Daily

6 months ago

Eli Lilly Rockets 12% After Solidifying Its Lead For A Weight-Loss Pill

Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025

VKTX

PR Newswire

6 months ago

Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025

Pfizer Halts Obesity Pill Development Amid Safety Concerns

VKTX

Zacks

6 months ago

Pfizer Halts Obesity Pill Development Amid Safety Concerns

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill

VKTX

TipRanks

6 months ago

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill

Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?

VKTX

Motley Fool

6 months ago

Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?

VKTX

Zacks

6 months ago

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

VKTX

Insider Monkey

6 months ago

Why Viking Therapeutics, Inc. (VKTX) Skyrocketed On Monday?

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

VKTX

Motley Fool

6 months ago

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

3 Magnificent Stocks That Could Double or More by 2030

VKTX

Motley Fool

6 months ago

3 Magnificent Stocks That Could Double or More by 2030

Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years?

VKTX

Motley Fool

6 months ago

Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years?

VKTX

MT Newswires

6 months ago

Goldman Sachs Initiates Viking Therapeutics With Neutral Rating, $30 Price Target

The Smartest Biotech Stocks to Buy With $50

VKTX

Motley Fool

6 months ago

The Smartest Biotech Stocks to Buy With $50

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?

VKTX

Motley Fool

6 months ago

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?

VKTX

Zacks

6 months ago

Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade

VKTX

Simply Wall St.

6 months ago

Viking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past Month

VKTX

Zacks

6 months ago

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

VKTX

Zacks

6 months ago

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study

VKTX

Investor's Business Daily

6 months ago

Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

VKTX

PR Newswire

6 months ago

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

VKTX

Zacks

6 months ago

Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

VKTX

Motley Fool

7 months ago

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street

VKTX

Motley Fool

7 months ago

1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?

VKTX

Motley Fool

7 months ago

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?

VKTX

Simply Wall St.

7 months ago

Viking Therapeutics (NasdaqCM:VKTX) Soars 10% With CordenPharma Manufacturing Agreement

VKTX

Zacks

7 months ago

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?

VKTX

Zacks

7 months ago

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?

VKTX

Zacks

7 months ago

How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma

VKTX

Insider Monkey

7 months ago

Why Viking Therapeutics Inc. (VKTX) Is Skyrocketing Today?

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

VKTX

Motley Fool

7 months ago

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

B. Riley sees two key positives in Viking manufacturing agreement

VKTX

TipRanks

7 months ago

B. Riley sees two key positives in Viking manufacturing agreement

VKTX

Zacks

7 months ago

VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply

Viking strikes $150m deal to secure supply of obesity drug

VKTX

Pharmaceutical Technology

7 months ago

Viking strikes $150m deal to secure supply of obesity drug

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.

VKTX

Investor's Business Daily

7 months ago

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.

Stellantis, Tesla, Viking Therapeutics: Market Minute

VKTX

Yahoo Finance Video

7 months ago

Stellantis, Tesla, Viking Therapeutics: Market Minute

Viking Therapeutics closer to bringing its Ozempic competitor to market

VKTX

Quartz

7 months ago

Viking Therapeutics closer to bringing its Ozempic competitor to market

VKTX

MT Newswires

7 months ago

Update: Viking Therapeutics Shares Fall After Manufacturing Deal With CordenPharma

H.C. Wainwright says Novo results support Viking obesity potential

VKTX

TipRanks

7 months ago

H.C. Wainwright says Novo results support Viking obesity potential

VKTX

Zacks

7 months ago

Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?

VKTX

MT Newswires

7 months ago

Latest Viking Therapeutics Inc. (VKTX) News on October 8, 2025

Share on Social Networks: